Stephens Investment Management Group LLC
Position in EXEL — Exelixis, Inc.
CIK 1314440
LITTLE ROCK, AR
Position in EXEL
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$147,451,698
+$39,175,893 QoQ
Shares Held
2,710,011
+7.3% QoQ
Ownership
1.09%
of shares outstanding
% of Portfolio
1.60%
of 13F equity value
Holder Rank
#20
of 751 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 94%
None 6%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Stephens Investment Management Group LLC holds $614,628,718 across 6 Biotechnology names. EXEL ranks #2 (24.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
475,609 | $150,335,248 | |
| 2 | EXEL |
Exelixis, Inc.
This page
|
2,710,011 | $147,451,698 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,392,819 | $109,015,943 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
1,875,304 | $106,536,020 | |
| 5 | TECH |
BIO-TECHNE Corp
|
944,697 | $66,742,843 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
281,832 | $34,546,966 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $147,451,698 | 2,710,011 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $108,275,805 | 2,524,500 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $111,302,822 | 2,539,421 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $103,710,742 | 2,511,156 | Shares | Defined | 2025-10-28 | |
| 2025-06-30 | $116,477,080 | 2,642,402 | Shares | Defined | 2025-07-30 | |
| 2025-03-31 | $111,371,542 | 3,016,564 | Shares | Defined | 2025-05-01 | |
| 2024-12-31 | $102,831,099 | 3,088,021 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $98,780,335 | 3,806,564 | Shares | Defined | 2024-10-28 | |
| 2024-06-30 | $87,194,992 | 3,880,507 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $92,870,392 | 3,913,628 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $98,518,869 | 4,106,664 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $91,673,597 | 4,195,588 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $79,571,421 | 4,163,863 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $79,082,551 | 4,074,320 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $64,917,890 | 4,047,250 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $63,867,948 | 4,073,211 | Shares | Defined | 2022-11-07 | |
| 2022-06-30 | $84,304,531 | 4,049,209 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $91,905,925 | 4,054,077 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $73,046,550 | 3,995,982 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $72,555,587 | 3,432,147 | Shares | Defined | 2021-10-27 | |
| 2021-06-30 | $53,260,339 | 2,923,180 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $53,418,527 | 2,364,698 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $28,295,609 | 1,409,846 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $35,331,081 | 1,445,034 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $35,339,886 | 1,488,622 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $24,590,521 | 1,428,021 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||